Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok). LSALT Peptide is developed for targeting organ inflammation often experienced in hospitalized COVID-19 patients. It focuses on therapeutic development of LSALT Peptide and other DPEP-1 targeting drug candidates for new indications where inflammation of the lungs, liver and kidneys is an unmet problem. It has additional technology platforms in its portfolio including AB569, which focuses on preventing antibiotic resistant bacterial infections; Borg, which is a peptide-solid surface interface, and MetaMx, which is a synthetic molecule that target brain tumor initiating cells and invasive glioma cells.


TSXV:ARCH - Post by User

Comment by SrPlataon Oct 13, 2021 10:06pm
90 Views
Post# 34003704

RE:RE:Putting The Arch Puzzle Pieces Together

RE:RE:Putting The Arch Puzzle Pieces TogetherThanks Antonius2, were both singing from the same Arch  hymnal. Just wait till we get P3 go ahead and price goes higher and we get off the OTCQB, and Toronto Venture exchange. Most big money investors don't touch companies that trade there. When the price goes higher then we can raise capital on Wall St. and get analyst coverage. Then the Healthcare Mutual Funds can buy and then when we hit a certain market cap (I believe around 300mm we could qualify for the Russell 3000). 

This is why when I first posted on this board I stressed this is where the small investor has a big advantage over the 'Big Boys" of Wall St. For example I am not precluded from buying Arch Bio by my CRO (Chief Risk Officer), there is no investment committee that I have to answer to, I can buy OTCQB stocks they can't. I don't have to wait till it goes into P3, most money managers in biotech do. Even if the manager loves the stock they are prohibited from buying in their individual accounts. Now you can throw everything I just stated about the small investor if your Wife won't let you or  hovers over you whining about what you bought is doing nothing but lose money and when is it going to go up. Fortunatly for me I have a wonderful wife  who does'nt know or care what stocks I buy, and I don't care what she buys for our home. 
<< Previous
Bullboard Posts
Next >>